UFC Addresses Ali Bagautinov’s Failed Drug Test for EPO

Written by Tom Ngo
July 11th, 2014

UFC Ali Bagautinov

For the second time in less than a month, another UFC fighter has failed a random drug test for erythropoietin (EPO). It has been announced former flyweight top contender Ali Bagautinov tested positive for the performance-enhancing substance prior to his UFC 174 title bout against champion Demetrious Johnson.

Bagautinov has been issued a one-year suspension, retroactive to his unanimous decision defeat to Johnson on June 14.

“UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO),” the UFC expressed in an official statement. “He was also informed that his positive test violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC. The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes.

“Bagautinov will serve a one-year suspension and must pass a drug test at the conclusion of his suspension before receiving clearance to compete in the UFC again.”

Bagautinov owns a 13-3 professional record. The Russian had rattled off 11 straight wins prior to getting trounced by Johnson.

The 29-year-old is currently rated #4 in the UFC’s Flyweight Rankings.

Bagautinov joins the likes of Vitor Belfort, Sonnen (twice) and Wanderlei Silva to fail random drug tests since February.

Sonnen was initially caught for Anastrozole and Clomiphene. Five weeks later he was forced into retirement after geetting popped again for human growth hormone (HGH), recombinant human erythropoietin (EPO) and human chorionic gonadotropin (hCG).

Is there any doubt that random drug testing is the way to go?

Don’t forget to follow @5thRound on Twitter, Facebook and Google+!